![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 4
2021
Gotlib, Jason; George, Tracy I.; Carter, Melody C.; Austen, K. Frank; Bochner, Bruce; Dwyer, Daniel F.; Lyons, Jonathan J.; Hamilton, Matthew J.; Butterfield, Joseph; Bonadonna, Patrizia; Weiler, Catherine; Galli, Stephen J.; Schwartz, Lawrence B.; Elberink, Hanneke Oude; Maitland, Anne; Theoharides, Theoharis; Ustun, Celalettin; Horny, Hans-Peter; Orfao, Alberto; Deininger, Michael; Radia, Deepti; Jawhar, Mohamad; Kluin-Nelemans, Hanneke; Metcalfe, Dean D.; Arock, Michel; Sperr, Wolfgang R.; Valent, Peter; Castells, Mariana und Akin, Cem
(2021):
Proceedings from the Inaugural American Initiative in Mast Cell Diseases(AIM) Investigator Conference.
In: Journal of Allergy and Clinical Immunology, Bd. 147, Nr. 6: S. 2043-2052
2020
Lange, Thoralf; Niederwieser, Christian; Gil, Arthur; Krahl, Rainer; von Grünhagen, Ulrich; Deininger, Michael; Pfirrmann, Markus und Niederwieser, Dietger
(2020):
No advantage of Imatinib in combination with hydroxyurea over Imatinib monotherapy: a study of the East German Study Group (OSHO) and the German CML study group.
In: Leukemia & Lymphoma, Bd. 61, Nr. 12: S. 2821-2830
2019
Valent, Peter; Orazi, Attilio; Savona, Michael R.; Patnaik, Mrinal M.; Onida, Francesco; Loosdrecht, Arjan A. van de; Haase, Detlef; Haferlach, Torsten; Elena, Chiara; Pleyer, Lisa; Kern, Wolfgang; Pemovska, Tea; Vladimer, Gregory; Schanz, Julie; Keller, Alexandra; Lübbert, Michael; Lion, Thomas; Sotlar, Karl; Reiter, Andreas; De Witte, Theo; Pfeilstöcker, Michael; Geissler, Klaus; Padron, Eric; Deininger, Michael; Orfao, Alberto; Horny, Hans-Peter; Greenberg, Peter L.; Arber, Daniel A.; Malcovati, Luca und Bennett, John M.
(2019):
Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions.
In: Haematologica, Bd. 104, Nr. 10: S. 1935-1949
2017
Hoffmann, Verena S.; Hasford, Jörg; Deininger, Michael; Cortes, Jörge; Baccarani, Michele und Hehlmann, Rüdiger
(2017):
Systematic review and meta-analysis of standard-dose imatinib vs. high-dose imatinib and second generation tyrosine kinase inhibitors for chronic myeloid leukemia.
In: Journal of Cancer Research and Clinical Oncology, Bd. 143, Nr. 7: S. 1311-1318